Copyright
©The Author(s) 2017.
World J Transplant. Apr 24, 2017; 7(2): 152-160
Published online Apr 24, 2017. doi: 10.5500/wjt.v7.i2.152
Published online Apr 24, 2017. doi: 10.5500/wjt.v7.i2.152
Was the assigned treatment adequately concealed prior to allocation? |
2 = method did not allow disclosure of assignment |
1 = small but possible chance of disclosure of assignment or unclear |
0 = quasi-randomized or open list/tables |
Were the outcomes of participants who withdrew described and included in the analysis (intention-to-treat)? |
2 = withdrawals well described and accounted for in analysis |
1 = withdrawals described and analysis not possible |
0 = no mention, inadequate mention, or obvious differences and no adjustment |
Were the outcome assessors blinded to treatment status? |
2 = effective action taken to blind assessors |
1 = small or moderate chance of unblinding of assessors |
0 = not mentioned or not possible |
Were the treatment and control groups comparable at entry? (likely confounders may be age, partial or total rupture, activity level, acute or chronic injury) |
2 = good comparability of groups, or confounding adjusted for in analysis |
1 = confounding small; mentioned but not adjusted for |
0 = large potential for confounding, or not discussed |
Were the participants blind to assignment status after allocation? |
2 = effective action taken to blind participants |
1 = small or moderate chance of unblinding of participants |
0 = not possible, or not mentioned (unless double-blind), or possible but not done |
Were the treatment providers blind to assignment status? |
2 = effective action taken to blind treatment providers |
1 = small or moderate chance of unblinding of treatment providers |
0 = not possible, or not mentioned (unless double-blind), or possible but not done |
Were care programes, other than the trial options, identical? |
2 = care programes clearly identical |
1 = clear but trivial differences |
0 = not mentioned or clear and important differences in care programes |
Were the inclusion and exclusion criteria clearly defined? |
2 = clearly defined |
1 = inadequately defined |
0 = not defined |
Were the interventions clearly defined? |
2 = clearly defined interventions are applied with a standardized protocol |
1 = clearly defined interventions are applied but the application protocol is not standardized |
0 = intervention and/or application protocol are poorly or not defined |
Were the outcome measures used clearly defined? (by outcome) |
2 = clearly defined |
1 = inadequately defined |
0 = not defined |
Were diagnostic tests used in outcome assessment clinically useful? (by outcome) |
2 = optimal |
1 = adequate |
0 = not defined, not adequate |
Was the surveillance active, and of clinically appropriate duration? |
2 = active surveillance and appropriate duration |
1 = active surveillance, but inadequate duration |
0 = surveillance not active or not defined |
- Citation: Simforoosh N, Shemshaki H, Nadjafi-Semnani M, Sotoudeh M. Living related and living unrelated kidney transplantations: A systematic review and meta-analysis. World J Transplant 2017; 7(2): 152-160
- URL: https://www.wjgnet.com/2220-3230/full/v7/i2/152.htm
- DOI: https://dx.doi.org/10.5500/wjt.v7.i2.152